img
img
About Us

RZAC ImmuneSAFE

RZAC ImmuneSAFE Sdn Bhd is a company incorporated in Malaysia since 2017.
The company deals with the supply of COVID TEST Kits, disposable products and medical equipments to the Government, Public & Private Hospitals, Pharmacies, General Practitioners and Private Agencies.
The company will provide all the necessary support and assistance to our clients as may be required in relation to any matter involving our products.
The company strives to provide the public with best quality and service at affordable prices.
The company has an experienced management team well versed with governmental requirements and procedures pertaining to the supply of such products.

Our Vision

  • To become the leading supplier of quality single use medical disposable

Our Mission

  • Satisfying customer needs by supplying quality and safe healthcare products
  • One stop centre for healthcare products
IMMUSAFE

COVID+ Biochip Test

It's a Multi-Domain, Fully Quantitative Serology Test for COVID-19.
Below are some technical details of this product:

Platform Proprietary surface which preserves protein folding and inhibits binding of non-specific proteins.

Content Multiple domains of SARS-CoV-2 Nucleocapsid proteins including full-length and numerous truncated versions.

Number of Arrays 24 arrays per slide (24 samples per slide).

Sample Type Human Serum/Plasma

Assay Type Single-colour fluorescently-labelled IgG antibody assay.

System Compatibility Any open-format microarray scanner (Example: Agilent, InnoScan, Genepix and Tecan Scanner).

symptoms
IMMUSAFE

Key Applications

Population antibody profiling for sero-prevalence research

Accurate determination of sero-prevalence by targeting multiple domains of SARS-CoV-2.

Determine the protective quality and quantity of antibodies produced

Identify individuals who have high titres of potentially neutralising antibodies against SARS-CoV-2 that may protect against reinfection or provide indications as to whether booster vaccinations are required.

Quantitative assessment of patient response in vaccination trials

Investigate SARS-CoV-2 specific immunoreactivity in patients and healthy individuals for vaccine development, safety and efficacy determination in clinical trials.